Dr. Reddy’s Laboratories (RDY) fair value: USD 4.03 a share
These figures are from 2025-03-31. Nothing newer has been filed in the 19 months since.
What is one share of Dr. Reddy’s Laboratories worth today if its net income keeps growing and the market keeps paying the multiple it has paid? Every starting value below comes from Dr. Reddy’s Laboratories's own filings and price history. Change any of them; nothing here is a forecast or advice.
What the price says
On its own free cash flow, growing -10.0% a year and fading, valued at 37.4x in 5 years and discounted at 10%, one share of Dr. Reddy’s Laboratories is worth about USD 4.03: 72% below the price of 14.17. Today's price assumes 22.1% growth a year on the same assumptions, against -11.0% a year over the last 4.0 years.
It trades at 49.1x its free cash flow today, against a five-year median of 37.4x.
Its share count has risen 0.1% a year over five years.
How much the answer moves
Fair value a share, USD, for the growth rate across and the return wanted down; everything else as above.
| Return wanted | -13.0% growth | -10.0% growth | -7.0% growth |
|---|---|---|---|
| 8% | 3.85 | 4.42 | 5.04 |
| 10% | 3.52 | 4.03 | 4.60 |
| 12% | 3.21 | 3.68 | 4.20 |
On assumptions, not a forecast, and not advice: the inputs are the company's own history, and the future need not repeat it.
Net income, as filed and projected
| Year | Growth | Net income |
|---|---|---|
| 1 | 25.0% | 838.75M |
| 2 | 22.5% | 1.03B |
| 3 | 20.2% | 1.24B |
| 4 | 18.2% | 1.46B |
| 5 | 16.4% | 1.70B |
How it is worked out
The figure is grown for each year of the horizon at a rate that fades, the multiple puts a market value on the last year's figure, and that value is divided over the share count as it will be by then. What that future price is worth today is it discounted at the return you want.
growth in year n = g × (1 − fade)n−1
figure in year n = figure in year n−1 × (1 + growth in year n)
future price = figure in year N × multiple ÷ (shares today × (1 + share change)N)
fair value = future price ÷ (1 + return wanted)N
The starting values are Dr. Reddy’s Laboratories's own: the latest twelve months of the figure as filed, what it actually grew at over four years, the company's own five-year median multiple of it or today's if that is lower, and what its share count actually did. A model this simple is only as good as the assumptions put into it, and the most important one -- that the business keeps growing -- is the one no filing can tell you.